About ASMB

Assembly Biosciences, Inc.is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. Themicrobiome program is developing novel oral live synthetic biotherapeutic candidates with Assembly's fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL technology.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ASMB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.01% 5.30728E-05 18 K 17632
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.01% 7.09234E-05 29 K 28690
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 293 K 293443
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.1% 0.001 939 K 939160
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.02% 0.0002 8.4 M 8414700
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.04% 0.0004 3.4 M 3422030
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 113 K 113148
LABU Direxion Daily S&P Biotech Bull 3X Shares 676.5 M 6.76479E+08 129 129 0.02% 0.000173719 425 K 424612
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.01% 0.00010104 162 K 161790

Wait, Before You Leave...